-
Company Insights
Innovation and Patenting activity of CLS Holdings Plc Q1 2024
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of CLS Holdings Plc Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TP-05 in Malaria
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TP-05 in Malaria report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TP-05 in Malaria Drug Details: Lotilaner is under development for the prevention of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CLS-12311 in Relapsing Remitting Multiple Sclerosis (RRMS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CLS-12311 in Relapsing Remitting Multiple Sclerosis (RRMS) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CLS-12311 in Relapsing Remitting Multiple Sclerosis (RRMS) Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CLS-12311 in Secondary Progressive Multiple Sclerosis (SPMS)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CLS-12311 in Secondary Progressive Multiple Sclerosis (SPMS) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.CLS-12311 in Secondary Progressive Multiple Sclerosis (SPMS) Drug Details: CLS-12311...
-
Product Insights
NewHearing Aid Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Hearing Aid Devices Pipeline Market Report Overview Hearing aid devices are the electronic device that amplifies and transmits sound, used by people with impaired hearing. The hearing aid devices pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TP-05 in Lyme Disease
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.TP-05 in Lyme Disease Drug Details:Lotilaner is under development for the prevention of lyme disease and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lotilaner in Blepharitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lotilaner in Blepharitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Lotilaner in BlepharitisDrug Details:Lotilaner is under development for the treatment of demodex blepharitis and...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AV-101 in Neuropathic Pain (Neuralgia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AV-101 in Neuropathic Pain (Neuralgia) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.AV-101 in Neuropathic Pain (Neuralgia) Drug Details:AV-101 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AV-101 in Drug-Induced Dyskinesia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AV-101 in Drug-Induced Dyskinesia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.AV-101 in Drug-Induced DyskinesiaDrug Details:AV-101 is under development for the treatment of neuropathic...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Furosemide in Congestive Heart Failure (Heart Failure)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Furosemide in Congestive Heart Failure (Heart Failure) Drug Details:Furosemide (Furoscix) is a sulfamoylanthranilic acid derivative, acts...